Yttrium

Medallion Commences Techno-Economic Assessment of Proprietary Rare-Earth Element Extraction Process  

Retrieved on: 
Tuesday, November 10, 2020

The techno-economic assessment (TEA) will aggregate results from extensive laboratory test work, process simulation and trade-off studies completed by Medallion over the past 5 years.

Key Points: 
  • The techno-economic assessment (TEA) will aggregate results from extensive laboratory test work, process simulation and trade-off studies completed by Medallion over the past 5 years.
  • Simulus is an ideal choice for this independent assessment of the Medallion Monazite Process as they delivered our comprehensive chemical process model and have a good breadth of rare-earth element expertise.
  • The Company has developed the Medallion Monazite Process, a proprietary method and related business model to achieve low-cost, near-term, REE production utilizing mineral sand monazite.
  • Medallion Resources has developed a proprietary process and related business model to achieve low-cost, near-term, rare-earth element (REE) production by exploiting monazite.

Crater Lake Summer Drilling Results Confirm Strong Scandium Resource Potential of the TG Mineralized Zone

Retrieved on: 
Wednesday, November 4, 2020

The total mineralized package was observed to have a true width of 110 m. Best scandium and rare earth intervals from this hole are presented in Table 1.

Key Points: 
  • The total mineralized package was observed to have a true width of 110 m. Best scandium and rare earth intervals from this hole are presented in Table 1.
  • The mineralized intervals show excellent lateral and vertical continuity of the favourable TG Zone target horizon (Figure 3).
  • To date, the TG Zone target shows the highest potential to host an economic scandium deposit.
  • Crater Lake is the only known significant primary bedrock resource of scandium in North America with the potential for supporting a new domestic scandium and rare earth supply chains.

Rare Earths Elements in High-Tech Industries: Market Analysis and Forecasts Amid China's Trade Embargo - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 28, 2020

The "Rare Earths Elements in High-Tech Industries: Market Analysis and Forecasts amid China's Trade Embargo" report from The Information Network has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Rare Earths Elements in High-Tech Industries: Market Analysis and Forecasts amid China's Trade Embargo" report from The Information Network has been added to ResearchAndMarkets.com's offering.
  • Rare earth elements (REE) are a group of 15-17 elements comprising the lanthanides (atomic numbers 57-71) plus yttrium and scandium.
  • Rare earths have a number of specific optical, magnetic and catalytic properties which drive demand across a wide range of applications.
  • In particular, an increasing shift to electric vehicles (EV) is expected to drive a significant increase in demand for rare earths, particularly neodymium.

Dr. Daniel J. Leeman MD Upgrades Skin Resurfacing Treatments with the Astanza DermaBlate in Austin, TX

Retrieved on: 
Monday, October 26, 2020

This year, Dr. Leeman added the Astanza DermaBlate to his practice to deliver faster, safer, and more effective fractional skin resurfacing treatments to his patients.

Key Points: 
  • This year, Dr. Leeman added the Astanza DermaBlate to his practice to deliver faster, safer, and more effective fractional skin resurfacing treatments to his patients.
  • "Skin resurfacing is an amazing procedure that tackles numerous skin conditions all in one treatment," said Dr. Leeman.
  • The Astanza DermaBlate is an industry-leading Erbium:YAG laser that performs fractional and ablative skin resurfacing treatments with little to no patient downtime.
  • Dr. Leeman is currently offering an end of year 15% discount on skin resurfacing treatments until December 31, 2020.

Medallion Resources Announces Results of Annual General Meeting and Board Changes

Retrieved on: 
Monday, October 26, 2020

Mark Saxon, Don Lay, Rod McKeen, David Shaw and Andrew Morden were elected to serve as directors of the Company (the Board).

Key Points: 
  • Mark Saxon, Don Lay, Rod McKeen, David Shaw and Andrew Morden were elected to serve as directors of the Company (the Board).
  • Furthermore, the Company announces the re-appointment of Davidson & Company LLP as auditor for the coming year and approval of the standard 10% stock option plan.
  • Medallion has developed the Medallion Monazite Process, a proprietary method and related business model to achieve low-cost, near-term, REE production utilizing mineral sand monazite.
  • Medallion Resources has developed a proprietary process and related business model to achieve low-cost, near-term, rare-earth element (REE) production by exploiting monazite.

Medallion Completes Siting Study for North American Rare-Earth Element Production Facility

Retrieved on: 
Wednesday, October 14, 2020

The Company has developed the Medallion Monazite Process, a proprietary method and related business model to achieve low-cost, near-term, REE production utilizing mineral sand monazite.

Key Points: 
  • The Company has developed the Medallion Monazite Process, a proprietary method and related business model to achieve low-cost, near-term, REE production utilizing mineral sand monazite.
  • The study has identified and ranked a range of regions that appear highly suitable for further investigation.
  • The benefits of the Medallion Monazite Process include the modular and scalable design and the need for only commercially-available chemicals.
  • Medallion Resources has developed a proprietary process and related business model to achieve low-cost, near-term, rare-earth element (REE) production by exploiting monazite.

Medallion Receives $741,000 from Warrant and Option Exercise

Retrieved on: 
Friday, October 2, 2020

The warrants and options were priced between $0.10 and $0.32 with an average exercise price of $0.21 per share.

Key Points: 
  • The warrants and options were priced between $0.10 and $0.32 with an average exercise price of $0.21 per share.
  • The recent over subscribed financing, in combination with the progressive exercise of warrants and options, has provided Medallion with an excellent working capital position, said Mark Saxon, President & CEO.
  • Medallion is focused on the development of a comprehensive rare earth element (REE) supply chain within North America.
  • Medallion Resources has developed a proprietary process and related business model to achieve low-cost, near-term, rare-earth element (REE) production by exploiting monazite.

Medallion Launches Comparative Study of Rare-Earth Element Separation Technologies

Retrieved on: 
Friday, September 25, 2020

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) Medallion or the Company), is pleased to announce the initiation of a comprehensive comparative technical and commercial review of existing and emerging rare-earth element (REE) separation technologies.

Key Points: 
  • VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) Medallion or the Company), is pleased to announce the initiation of a comprehensive comparative technical and commercial review of existing and emerging rare-earth element (REE) separation technologies.
  • Medallion has identified four leading and approximately ten additional groups with potential technologies for REE separation, alongside the industry incumbent liquid-liquid solvent extraction, said Mark Saxon, CEO & President.
  • To date, Medallion has worked closely with two US based private REE separation companies with distinct technology platforms.
  • Medallion Resources has developed a proprietary process and related business model to achieve low-cost, near-term, rare-earth element (REE) production by exploiting monazite.

CIRT-EU Registry for SIR-Spheres® Therapy presented at CIRSE 2020 Summit

Retrieved on: 
Tuesday, September 15, 2020

"I am extremely proud of the CIRSE team for their hard work the last six years to successfully complete this registry," said Helmberger.

Key Points: 
  • "I am extremely proud of the CIRSE team for their hard work the last six years to successfully complete this registry," said Helmberger.
  • CIRT EU is the largest observational registry run exclusively by CIRSE and funded by a grant provided by Sirtex Medical Europe.
  • Sirtex's current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres Y-90 resin microspheres.
  • Selective internal radiation therapy (SIRT) with SIR-Spheres Y-90 resin microspheres is a prescription device for the treatment of inoperable liver tumours.